Thiazolinedione treatment in PCOS-an update

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Polycystic ovary syndrome (PCOS) is characterised by anovulation, hyperandrogenism, and polycystic ovaries. Fifty percent of patients fulfil the criteria for the metabolic syndrome. The pathogenesis of PCOS may be looked as a vicious cycle involving hyperandrogenemia, central obesity, and insulin resistance and medical treatment should aim at breaking this cycle. Lifestyle intervention, oral contraceptives, and insulin sensitises such as metformin are the most commonly used treatment modalities. The thiazolidinediones rosiglitazone and pioglitazone were recently applied as insulin sensitising treatment in patients with PCOS. Thiazolidinediones activate the transcription of genes that affect glucose and lipid metabolism mediating decreased free fatty acid levels and decreased visceral fat mass. In the present article, we give an overview of the diverse effects of glitazone treatment in patients with PCOS. We review the studies comparing glitazone versus metformin and oral contraceptive treatment and recommend which patients should be treated with glitazones in daily praxis.
Original languageEnglish
JournalGynecological Endocrinology
Volume26
Issue number11
Pages (from-to)791-803
Number of pages13
ISSN0951-3590
DOIs
Publication statusPublished - 1. Nov 2010

Fingerprint

Thiazolidinediones
Polycystic Ovary Syndrome
rosiglitazone
pioglitazone
Oral Contraceptives
Insulin
Hyperandrogenism
Intra-Abdominal Fat
Abdominal Obesity
Lipid Metabolism
Nonesterified Fatty Acids
Insulin Resistance
Ovary

Cite this

@article{d94a992db3364848a859e4bbd3ba8da8,
title = "Thiazolinedione treatment in PCOS-an update",
abstract = "Polycystic ovary syndrome (PCOS) is characterised by anovulation, hyperandrogenism, and polycystic ovaries. Fifty percent of patients fulfil the criteria for the metabolic syndrome. The pathogenesis of PCOS may be looked as a vicious cycle involving hyperandrogenemia, central obesity, and insulin resistance and medical treatment should aim at breaking this cycle. Lifestyle intervention, oral contraceptives, and insulin sensitises such as metformin are the most commonly used treatment modalities. The thiazolidinediones rosiglitazone and pioglitazone were recently applied as insulin sensitising treatment in patients with PCOS. Thiazolidinediones activate the transcription of genes that affect glucose and lipid metabolism mediating decreased free fatty acid levels and decreased visceral fat mass. In the present article, we give an overview of the diverse effects of glitazone treatment in patients with PCOS. We review the studies comparing glitazone versus metformin and oral contraceptive treatment and recommend which patients should be treated with glitazones in daily praxis.",
author = "Dorte Glintborg and Marianne Andersen",
year = "2010",
month = "11",
day = "1",
doi = "10.3109/09513590.2010.491572",
language = "English",
volume = "26",
pages = "791--803",
journal = "Gynecological Endocrinology",
issn = "0951-3590",
publisher = "Taylor & Francis",
number = "11",

}

Thiazolinedione treatment in PCOS-an update. / Glintborg, Dorte; Andersen, Marianne.

In: Gynecological Endocrinology, Vol. 26, No. 11, 01.11.2010, p. 791-803.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Thiazolinedione treatment in PCOS-an update

AU - Glintborg, Dorte

AU - Andersen, Marianne

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Polycystic ovary syndrome (PCOS) is characterised by anovulation, hyperandrogenism, and polycystic ovaries. Fifty percent of patients fulfil the criteria for the metabolic syndrome. The pathogenesis of PCOS may be looked as a vicious cycle involving hyperandrogenemia, central obesity, and insulin resistance and medical treatment should aim at breaking this cycle. Lifestyle intervention, oral contraceptives, and insulin sensitises such as metformin are the most commonly used treatment modalities. The thiazolidinediones rosiglitazone and pioglitazone were recently applied as insulin sensitising treatment in patients with PCOS. Thiazolidinediones activate the transcription of genes that affect glucose and lipid metabolism mediating decreased free fatty acid levels and decreased visceral fat mass. In the present article, we give an overview of the diverse effects of glitazone treatment in patients with PCOS. We review the studies comparing glitazone versus metformin and oral contraceptive treatment and recommend which patients should be treated with glitazones in daily praxis.

AB - Polycystic ovary syndrome (PCOS) is characterised by anovulation, hyperandrogenism, and polycystic ovaries. Fifty percent of patients fulfil the criteria for the metabolic syndrome. The pathogenesis of PCOS may be looked as a vicious cycle involving hyperandrogenemia, central obesity, and insulin resistance and medical treatment should aim at breaking this cycle. Lifestyle intervention, oral contraceptives, and insulin sensitises such as metformin are the most commonly used treatment modalities. The thiazolidinediones rosiglitazone and pioglitazone were recently applied as insulin sensitising treatment in patients with PCOS. Thiazolidinediones activate the transcription of genes that affect glucose and lipid metabolism mediating decreased free fatty acid levels and decreased visceral fat mass. In the present article, we give an overview of the diverse effects of glitazone treatment in patients with PCOS. We review the studies comparing glitazone versus metformin and oral contraceptive treatment and recommend which patients should be treated with glitazones in daily praxis.

U2 - 10.3109/09513590.2010.491572

DO - 10.3109/09513590.2010.491572

M3 - Journal article

VL - 26

SP - 791

EP - 803

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

IS - 11

ER -